Design Phase 3 with the commercial case built in
Bring commercial input into the protocol before it is locked, so the trial generates the evidence payers, prescribers and partners will need.
Pharmaceutical launch excellence
Launches that land, from Phase 3 readout to year one.
Senior, independent support for pharma and biotech teams who need every function launch-ready at the same moment. You work directly with senior practitioners, not a junior team.
Sound familiar?
- 01"Phase 3 reads out next year and we don't have a launch plan everyone trusts."
- 02"Each function says it's on track, but nobody can see the whole picture."
- 03"We're a small biotech and need to prove the commercial case before we sell or scale."
- 04"Our launch committee meets, but decisions don't stick."
Trusted by teams at leading pharmaceutical companies
The method
Accelerated Launch Readiness
A milestone-based readiness system that brings forward the decisions most teams leave too late, so medical, market access, commercial and supply share one definition of "ready" and one plan to get there.
Whether you have two years or a matter of months, the milestones scale to the time you have. It works for global teams with country overlays, for specialty and primary care, and for companies launching their first product or their fiftieth.
Talk through your launchWhat every team gets
- Strategic choices locked early: positioning, evidence and access priorities
- A cross-functional plan with owners and quality standards for every deliverable
- Milestones compressed and prioritised to fit your timeline, however short
- Go / no-go readiness reviews across markets and functions
- First-year performance tracking and course correction
Senior and hands-on
Every engagement is led and delivered by senior practitioners who have sat in your seat. No handover to a junior team after the pitch.
Evidence first
Every figure sourced and checkable. In a regulated industry, credibility depends on it.
Yours to keep
Tools your team carries into its own systems and reuses for the next launch.
For biotech
Commercial thinking belongs before Phase 3, not after it.
For small and emerging biotechs, the commercial story starts long before launch. The choices made when Phase 3 is designed (comparator, endpoints, patient-reported outcomes, target population) decide what you can claim, who will pay, and what your asset is worth to a partner or acquirer.
We bring senior commercial rigour in early, sized for a lean team, whether you plan to launch yourself, partner or sell.
Build an asset story buyers believe
Market opportunity, positioning and a credible launch plan that stand up in partnering discussions and due diligence.
Scale for launch
If you're taking it to market yourself: the capabilities, plan and governance to launch well, without building a big-pharma machine.
Free · 2 minutes
How launch-ready are you, really?
Ten coaching questions to ask yourself and your team. No score and no sales pitch: just the questions that test the assumptions and gaps worth talking about at your next leadership meeting.
Start the questionsAlso available
The same thinking, applied beyond the launch
Brand planning review
An independent, structured assessment of brand plans that pinpoints the process, capability and culture changes with the biggest impact.
Governance and operating committees
Meetings designed around decisions, with crisp minutes, owned actions and confidential follow-through.
Organisational strategy
Long-range organisational and commercial strategy for pharma businesses, grounded in honest benchmarking against peers.
Facilitated workshops
We act as provocateur and guide, not lecturer, so your team does the thinking and owns the decisions.
Selected work
Recent engagements
Specialty pharma · Europe
A launch-readiness framework the whole business can follow
Designed a milestone structure counting down to launch, giving every function shared definitions of readiness. Now being built into the client's own intranet.
Pharma · Multi-brand portfolio
A portfolio brand review that sharpened planning and execution
Reviewed brand planning across multiple brands in a pharma company, identifying the process, capability and culture improvements needed to strengthen how brands are planned and delivered.
Specialty care · Leadership
Operating committee support that turns meetings into decisions
Ongoing support for a senior operating committee: structured summaries, owned actions and confidential follow-up after every session.
Charity · Sport for development
A 10-year strategy for a national sports foundation
Advised on long-term organisational strategy, benchmarking against charities that use sport as a vehicle for social change.
About
Hi, I'm Mike.
Before founding MiraVeta in 2017, I spent 15+ years in commercial leadership at AstraZeneca, Roche, Pfizer and LEO Pharma. Much of that time was spent leading cross-functional teams and working in detail with market access, medical, supply and sales to get products launched and growing.
I've sat in the seats our clients sit in, so I know how strategy gets made and where it gets stuck. MiraVeta brings together practitioners with the same depth of senior industry experience, so every engagement is led by people who have done the job.
Away from client work I coach girls' rugby. It's taught me more about facilitation than any training course: get a group to trust a plan, then let them run it under pressure.
Beyond the work
Backing community and girls' rugby
MiraVeta sponsors kit and events for community rugby clubs and for girls' rugby, helping more people get on the pitch and stay in the game.
Sport builds confidence, teamwork and resilience that last well beyond the final whistle. The same things make great launch teams.
Let's talk about your launch.
A 30-minute call, no obligation. You'll leave with at least one useful idea, whether or not we work together.
What happens next
- 1We reply personally within one working day.
- 2We talk through where your launch is and what's worrying you.
- 3If there's a fit, you get a short written proposal with clear scope and fees.
Loading the form…